BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population
医学
紫杉醇
药理学
肿瘤科
内科学
化疗
作者
Nicholas C. Turner,Ashley E. Alarcon-Rozas,Anne Armstrong,M. Philco,Yamil Alonso Lopez Chuken,Marie‐Paule Sablin,Kenji Tamura,Armando Villanueva,José Alejandro Pérez Fidalgo,S.Y. Amy Cheung,Claire Corcoran,Marie Cullberg,Barry R. Davies,Elza C. de Bruin,Andrew Foxley,Justin P.O. Lindemann,Rhiannon Maudsley,Michele Moschetta,E. Outhwaite,Martin Pass